ReviewTherapeutic advances in hematology2014

Practical management of patients with chronic myeloid leukemia who develop tyrosine kinase inhibitor-resistant BCR-ABL1 mutations.

Jing Ai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.